
---
title: '阿尔茨海默病的主要贡献者被发现'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202208/15/160923wgwtytgtq5waztdd.jpg'
author: 科学网
comments: false
date: Mon, 15 Aug 2022 16:04:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202208/15/160923wgwtytgtq5waztdd.jpg'
---

<div>   
<p style="line-height: 3em;"><span style="font-family: "times new roman"; font-size: 24px;">阿尔茨海默病的主要贡献者被发现</span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">诸平</span></p><p style="line-height: 2em; text-align: center;"><a href="https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet#changes" target="_self"><span style="font-size: 18px; font-family: "times new roman";"><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202208/15/160923wgwtytgtq5waztdd.jpg" title alt="360截图20220815160901453.jpg" referrerpolicy="no-referrer"></span></a><span style="font-size: 18px; font-family: "times new roman";"><br></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">据美国路易斯安那州立大学健康科学中心（</span><a href="https://www.lsuhsc.edu/" target="_blank" style="font-size: 18px; font-family: "times new roman";">Louisiana State University Health Sciences Center</a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-family: 宋体;">）</span>2022<span style="font-family: 宋体;">年</span>8<span style="font-family: 宋体;">月</span>9<span style="font-family: 宋体;">日提供的消息，阿尔茨海默病（</span><a href="https://www.sciencedaily.com/releases/2022/08/220809141235.htm" target="_blank">Alzheimer's disease</a><span style="font-family: 宋体;">简称</span>AD<span style="font-family: 宋体;">）的主要贡献者已被发现（</span></span><a href="https://www.sciencedaily.com/releases/2022/08/220809141235.htm" style="font-size: 18px; font-family: "times new roman";" target="_blank">Major contributor to Alzheimer's disease discovered</a><span style="font-size: 18px; font-family: "times new roman";">）。</span><br></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">研究报告了一条从肠道开始并以脑细胞中一种有效的促炎毒素结束的途径，该毒素有助于阿尔茨海默病</span> (AD) <span style="font-size: 18px; font-family: 宋体;">的发展。他们还报告了一种潜在的简单方法来对其进行防止。相关研究结果于</span>2022<span style="font-size: 18px; font-family: 宋体;">年</span>6<span style="font-size: 18px; font-family: 宋体;">月</span>24<span style="font-size: 18px; font-family: 宋体;">日已经在《神经学前沿》（</span></span><a href="http://dx.doi.org/10.3389/fneur.2022.900048" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Frontiers in Neurology</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）杂志网站发表——</span>Aileen I. Pogue, Vivian R. Jaber, Nathan M. Sharfman, </span><a href="https://www.frontiersin.org/people/u/104994" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Yuhai Zhao</span></a><span style="font-size: 18px; font-family: "times new roman";">, </span><a href="https://www.frontiersin.org/people/u/7170" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Walter J. Lukiw</span></a><span style="font-size: 18px; font-family: "times new roman";">. Downregulation of Neurofilament Light Chain Expression in Human Neuronal-Glial Cell Co-Cultures by a Microbiome-Derived Lipopolysaccharide-Induced miRNA-30b-5p. Frontiers in Neurology, Published: 24 June 2022; 13. DOI: </span><a href="http://dx.doi.org/10.3389/fneur.2022.900048" target="_blank" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: "times new roman";">10.3389/fneur.2022.900048</span></a><span style="font-size: 18px; font-family: "times new roman";">. </span></p><p style="line-height: 2em;"><a href="https://doi.org/10.3389/fneur.2022.900048" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">https://doi.org/10.3389/fneur.2022.900048</span></a></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">参与此项研究的除了来自美国路易斯安那州立大学（</span>Louisiana State University<span style="font-size: 18px; font-family: 宋体;">简称</span>LSU<span style="font-size: 18px; font-family: 宋体;">）健康科学中心的研究人员之外，还有来自加拿大多伦多</span>Alchem<span style="font-size: 18px; font-family: 宋体;">生物技术研究公司（</span>Alchem Biotech Research, Toronto, Canada<span style="font-size: 18px; font-family: 宋体;">）的研究人员。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">由路易斯安那州立大学健康新奥尔良神经科学中心</span>(LSU Health New Orleans Neuroscience Center) <span style="font-size: 18px; font-family: 宋体;">和细胞生物学和解剖学、神经学和眼科学室的赵玉海博士（</span>Dr. Yuhai Zhao<span style="font-size: 18px; font-family: 宋体;">音译）和</span> <span style="font-size: 18px; font-family: 宋体;">沃尔特·卢金博士（</span>Dr. </span><a href="https://www.frontiersin.org/people/u/7170" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">Walter J. Lukiw</span></a><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">）领导这项研究，首次报道了一种始于肠道、以脑细胞中一种强效促炎毒素（</span>pro-inflammatory toxin<span style="font-size: 18px; font-family: 宋体;">）结束的途径，有助于阿尔茨海默病</span>(Alzheimer's disease<span style="font-size: 18px; font-family: 宋体;">简称</span>AD)<span style="font-size: 18px; font-family: 宋体;">的发展。他们还报告了一种简单的预防方法。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">研究人员发现的证据表明，一种含有非常有效的微生物产生的神经毒素脂多糖（</span><a href="https://www.sciencedaily.com/releases/2022/08/220809141235.htm" target="_blank">lipopolysaccharide</a><span style="font-size: 18px; font-family: 宋体;">简称</span>LPS<span style="font-size: 18px; font-family: 宋体;">）的分子来自人类胃肠</span>(gastrointestinal<span style="font-size: 18px; font-family: 宋体;">简称</span>GI)<span style="font-size: 18px; font-family: 宋体;">道中的革兰氏阴性细菌脆弱拟杆菌（</span><em>Bacteroides fragilis</em><span style="font-size: 18px; font-family: 宋体;">），它会产生一种称为</span>BF-LPS<span style="font-size: 18px; font-family: 宋体;">的神经毒素。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">沃尔特·卢金博士说：</span>“<span style="font-size: 18px; font-family: 宋体;">一般而言，</span>LPS <span style="font-size: 18px; font-family: 宋体;">可能是已知的最有效的微生物来源的促炎性神经毒性糖脂（</span><a href="https://www.sciencedaily.com/releases/2022/08/220809141235.htm" target="_blank">pro-inflammatory neurotoxic glycolipids</a><span style="font-size: 18px; font-family: 宋体;">）。许多实验室，包括我们自己的实验室，都在受阿尔茨海默病影响的人脑神经元中检测到不同形式的</span>LPS<span style="font-size: 18px; font-family: 宋体;">。”</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">在这项研究中，研究人员详细介绍了</span>BF-LPS<span style="font-size: 18px; font-family: 宋体;">从肠道到大脑的途径及其作用机制。</span>BF-LPS<span style="font-size: 18px; font-family: 宋体;">从胃肠道漏出，通过循环系统穿过血脑屏障，进入脑室。然后它会增加脑细胞的炎症并抑制神经元特异性神经丝光</span><a href="https://www.sciencedaily.com/releases/2022/08/220809141235.htm" target="_blank">neurofilament light</a><span style="font-size: 18px; font-family: 宋体;">简称</span>NF-L)<span style="font-size: 18px; font-family: 宋体;">，这是一种支持细胞完整性的蛋白质。这种蛋白质的缺乏会导致进行性神经元细胞萎缩，并最终导致细胞死亡，正如在受</span>AD<span style="font-size: 18px; font-family: 宋体;">影响的神经元中所观察到的那样。他们还报告说，摄入足够的膳食纤维可以阻止这一过程。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">这种新描述的病理途径的新特征是三重的。</span>AD<span style="font-size: 18px; font-family: 宋体;">刺激途径始于我们内部</span>——<span style="font-size: 18px; font-family: 宋体;">在我们的胃肠道微生物群中</span>——<span style="font-size: 18px; font-family: 宋体;">因此非常</span>“<span style="font-size: 18px; font-family: 宋体;">本地化</span>”<span style="font-size: 18px; font-family: 宋体;">并且在我们的一生中都很活跃。高效神经毒素</span>BF-LPS<span style="font-size: 18px; font-family: 宋体;">是基于胃肠道的微生物代谢的天然副产品。微生物组中脆弱拟杆菌的丰度是神经毒素</span>BF-LPS <span style="font-size: 18px; font-family: 宋体;">的来源，可以通过膳食纤维摄入来调节。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">“<span style="font-size: 18px; font-family: 宋体;">换句话说，基于饮食的方法来平衡微生物组中的微生物可能是一种有吸引力的方法，可以改变</span>AD<span style="font-size: 18px; font-family: 宋体;">相关微生物的产肠毒素形式（</span><a href="https://www.sciencedaily.com/releases/2022/08/220809141235.htm" target="_blank">enterotoxigenic forms</a><span style="font-size: 18px; font-family: 宋体;">）的丰度、物种形成和复杂性，以及它们对高神经毒性微生物的病理排放的潜力</span>——<span style="font-size: 18px; font-family: 宋体;">衍生的分泌物包括</span>BF-LPS<span style="font-size: 18px; font-family: 宋体;">和其他形式的</span>LPS<span style="font-size: 18px; font-family: 宋体;">，</span>”<span style="font-size: 18px; font-family: 宋体;">沃尔特·卢金解释说。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">研究人员得出结论，对胃肠道</span>-<span style="font-size: 18px; font-family: 宋体;">中枢神经系统轴和胃肠道微生物组与阿尔茨海默病之间的相互作用的进一步了解，对于阿尔茨海默病和其他致命的、进行性的、与年龄相关的神经退行性疾病的临床治疗有很大的潜力。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">据估计，美国人平均每天吃</span>10-15 g<span style="font-size: 18px; font-family: 宋体;">纤维。美国农业部建议</span>50<span style="font-size: 18px; font-family: 宋体;">岁以下女性每天摄入</span>25 g<span style="font-size: 18px; font-family: 宋体;">，男性每天摄入</span>38 g<span style="font-size: 18px; font-family: 宋体;">。</span>50<span style="font-size: 18px; font-family: 宋体;">岁以上的女性和男性每天应分别摄入</span>21 g<span style="font-size: 18px; font-family: 宋体;">和</span>30 g<span style="font-size: 18px; font-family: 宋体;">。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">根据美国国立卫生研究院</span>(National Institutes of Health)<span style="font-size: 18px; font-family: 宋体;">的数据，阿尔茨海默病是痴呆症患者最常见的诊断，也是美国人的第六大死因。专家估计，</span>65<span style="font-size: 18px; font-family: 宋体;">岁及以上的美国人多达</span>580<span style="font-size: 18px; font-family: 宋体;">万患有阿尔茨海默病，预计到</span>2050<span style="font-size: 18px; font-family: 宋体;">年，美国的患病人数将增加到</span>1380<span style="font-size: 18px; font-family: 宋体;">万。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">该研究得到了路易斯安那州立大学健康新奥尔良神经科学中心、布朗基金会（</span>Brown Foundation<span style="font-size: 18px; font-family: 宋体;">）、乔和多萝西</span>·<span style="font-size: 18px; font-family: 宋体;">多塞特科学健康老龄化创新奖（</span>Joe and Dorothy Dorsett Innovation in Science Health Aging Award<span style="font-size: 18px; font-family: 宋体;">）以及美国国立卫生研究院国家老龄化研究所（</span>National Institutes on Aging of the National Institutes of Health<span style="font-size: 18px; font-family: 宋体;">）的资助。</span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;"></span></span></p><p style="line-height: 2em;"><span style="font-size: 18px; font-family: "times new roman";">上述介绍，仅供参考。欲了解更多信息，敬请注意浏览</span><a href="http://dx.doi.org/10.3389/fneur.2022.900048" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";" target="_blank"><span style="font-size: 18px; font-family: "times new roman";">原文</span></a><span style="font-size: 18px; font-family: "times new roman";">或者</span><a href="https://www.lsuhsc.edu/newsroom/LSU%20Health%20New%20Orleans%20Discovers%20Major%20Contributor%20to%20Alzheimer%E2%80%99s%20Disease.html" target="_blank" style="text-decoration: underline; font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: "times new roman";"><span style="font-size: 18px; font-family: 宋体;">相关报道（</span>Materials<span style="font-size: 18px; font-family: 宋体;">）</span></span></a><span style="font-size: 18px; font-family: "times new roman";">。</span></p><p style="line-height: 2em;"><a href="https://www.frontiersin.org/articles/10.3389/fneur.2022.900048/full#h1" style="font-size: 18px; font-family: "arial black", "avant garde";" target="_blank">Abstract</a><br></p><p style="line-height: 2em;"><span style="color: #282828; background: #F7F7F7; font-size: 18px; font-family: "times new roman";">Microbiome-derived Gram-negative bacterial lipopolysaccharide (LPS) has been shown by multiple laboratories to reside within Alzheimer's disease (AD)-affected neocortical and hippocampal neurons. LPS and other pro-inflammatory stressors strongly induce a defined set of NF-kB (p50/p65)-sensitive human microRNAs, including a brain-enriched <em>Homo sapien</em> microRNA-30b-5p (hsa-miRNA-30b-5p; miRNA-30b). Here we provide evidence that this neuropathology-associated miRNA, known to be upregulated in AD brain and LPS-stressed human neuronal-glial (HNG) cells in primary culture targets the neurofilament light (NF-L) chain mRNA 3'-untranslated region (3'-UTR), which is conducive to the post-transcriptional downregulation of NF-L expression observed within both AD and LPS-treated HNG cells. A deficiency of NF-L is associated with consequent atrophy of the neuronal cytoskeleton and the disruption of synaptic organization. Interestingly, miRNA-30b has previously been shown to be highly expressed in amyloid-beta (Aβ) peptide-treated animal and cell models, and Aβ peptides promote LPS entry into neurons. Increased miRNA-30b expression induces neuronal injury, neuron loss, neuronal inflammation, impairment of synaptic transmission, and synaptic failure in neurodegenerative disease and transgenic murine models. This gut microbiota-derived LPS-NF-kB-miRNA-30b-NF-L pathological signaling network: <strong>(i)</strong> underscores a positive pathological link between the LPS of gastrointestinal (GI)-tract microbes and the inflammatory neuropathology, disordered cytoskeleton, and disrupted synaptic signaling of the AD brain and stressed brain cells; and <strong>(ii)</strong> is the first example of a microbiome-derived neurotoxic glycolipid having significant detrimental miRNA-30b-mediated actions on the expression of NF-L, an abundant neuron-specific filament protein known to be important in the maintenance of neuronal cell shape, axonal caliber, and synaptic homeostasis.</span></p><p><br></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自诸平科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-212210-1351279.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-212210-1351279.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-212210-1351147.html" target="_black">低价铝配合物：过渡金属催化的重要里程碑</a><br>下一篇：<a href="http://blog.sciencenet.cn/blog-212210-1351392.html" target="_black">利用磁体制造氧气可以帮助宇航员轻松呼吸</a>                    <!--大赛结束-->
                                        
  
</div>
            